EMIS Wins Innovation Award for Revolutionary Clinical Trial Recruitment Platform
核心洞察
EMIS (搜索)'s innovative Recruit (搜索) platform has won the 2024 Pharmaceutical Technology Excellence Award for transforming clinical trial recruitment by seamlessly integrating with GP clinical systems.
The platform has demonstrated remarkable success, supporting 11 trials and reaching over 500,000 potential participants through more than 1,000 GP practices covering 11 million patients.
Recruit (搜索) addresses a critical industry challenge, where 80% of trials face recruitment delays and 30% of trial costs are spent on patient recruitment, by streamlining the process within existing GP workflows.
EMIS (搜索) has secured the Innovation Award at the 2024 Pharmaceutical Technology Excellence Awards for its groundbreaking clinical trial recruitment tool, Recruit (搜索), marking a significant advancement in addressing one of the pharmaceutical industry's most persistent challenges.
The innovative platform directly tackles the widespread problem of patient recruitment in clinical trials, where industry data shows that 80% of trials experience delays due to recruitment difficulties, with recruitment phases consuming approximately 30% of overall trial costs.
Revolutionary Integration with Primary Care Systems
Recruit (搜索)'s distinctive approach lies in its seamless integration with EMIS Web (搜索), the existing GP clinical system. This integration enables healthcare professionals to identify and engage potential trial participants as part of their regular workflow, eliminating traditional recruitment bottlenecks.
The platform leverages the trusted relationship between GPs and patients, making it easier for healthcare providers to connect eligible participants with appropriate clinical trials. By embedding the recruitment tool directly within the primary care clinical software, EMIS (搜索) has created a natural extension of daily clinical practice.
Demonstrated Impact and Scale
The success of Recruit (搜索) is evidenced by its impressive reach and adoption metrics. The platform has:
- Supported 11 clinical trials
- Facilitated invitations to over 500,000 potential participants
- Been activated across more than 1,000 GP practices
- Reached a patient pool exceeding 11 million individuals
Advanced Features and Functionality
Recruit (搜索)'s innovative design incorporates several key features that set it apart:
- Real-time candidate identification within GP dashboards
- Streamlined consent acquisition process
- Adjustable cohort selection capabilities
- Scalable engagement programs matched to trial screening capacity
The platform's flexibility allows pharmaceutical organizations to fine-tune recruitment efforts according to trial site capacity, ensuring optimal participant flow and resource utilization.
User Experience and Clinical Integration
Healthcare professionals have reported positive feedback on Recruit (搜索)'s user experience, highlighting its intuitive design and seamless integration into daily clinical practice. The tool surfaces potential candidates directly within the GP's workflow, significantly reducing administrative burden while supporting clinical research initiatives.
The platform's success demonstrates EMIS (搜索)'s deep understanding of primary care dynamics and its commitment to developing solutions that enhance both clinical efficiency and patient access to innovative treatments.
Impact on Clinical Research Landscape
By addressing the longstanding challenge of trial recruitment, Recruit (搜索) represents a significant step forward in accelerating clinical research timelines. The platform's ability to efficiently connect pharmaceutical organizations with healthcare providers has established a new benchmark for trial recruitment efficiency.
EMIS (搜索)'s innovation comes at a crucial time when streamlining clinical trial processes is essential for bringing new treatments to patients more quickly. The platform's success in bridging the gap between primary care and clinical research demonstrates its potential to significantly impact the future of drug development and patient care.